Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening Network
European Journal of Cancer2013Vol. 50(1), pp. 185–192
Citations Over TimeTop 10% of 2013 papers
Elsebeth Lynge, Antonio Ponti, Ted A. James, Ondřej Májek, My von Euler‐Chelpin, Ahti Anttila, Patricia Fitzpatrick, Alfonso Frigerio, Masaaki Kawai, Astrid Scharpantgen, Mireille J. M. Broeders, Solveig Hofvind, Carmen Vidal, María Ederra, Dolores Salas, Jean‐Luc Bulliard, Mariano Tomatis, Karla Kerlikowske, Stephen H. Taplin
Abstract
Considerable international variation was found in DCIS detection. This variation could not be fully explained by variation in incidence nor in breast cancer detection rates. It suggests the potential for wide discrepancies in management of DCIS resulting in overtreatment of indolent DCIS or undertreatment of potentially curable disease. Comprehensive cancer registration is needed to monitor DCIS detection. Efforts to understand discrepancies and standardise management may improve care.
Related Papers
- → Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging(2005)212 cited
- → Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging(2006)33 cited
- Sensitivity of mammography and ultrasonography on detecting abnormal findings of ductal carcinoma in situ.(2007)
- → Mammography to screen asymptomatic women for breast cancer(1984)29 cited
- → Physicians’ Awareness of Mammography Charges(1994)3 cited